Topics

High-grade gliomas | Treatment | Clinical trials | Hypoxia-targeting Radioligand Therapy

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Hypoxia-targeting Radioligand Therapy

Kurihara H, Narita Y, Ito K, Sato H, Miyakita Y, Takahashi M, Ohno M, Yanagisawa S, Okita NT, Sadachi R, Machida R, Tateishi K, Yoshii Y, Waki A, Hashimoto H, Suzuki H, Zhang MR, Kawamura K, Honda N, Yoshimoto M, Matsumoto H.
First-in-human phase I study of hypoxia-targeting ⁶⁴Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
ESMO Open. 2026 Jul 10;11(8):108249. doi: 10.1016/j.esmoop.2026.108249. PMID: 42431136. Trial registration ID: jRCT2091220362. ˍ